&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2024-04-03, 20:17
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-03-13, 22:36
KronosMD Inc CEO to attend the Annual Roth Investor
CEO Dr. Greg Rubin to meet with institutional investors...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-03-08, 21:41
IBN Returns as a Media Partner for FFCON23: REGEN
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- via CryptoCurrencyWire -- IBN (“InvestorBrandNetwork”), a multifaceted communications organization engaged...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-03-01, 21:29
ZyVersa Therapeutics to Participate in a Fireside Chat at
CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease,...
